Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Non-Hodgkin-Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02341209
What this trial is testing

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome
Rochester General Hospital 1
Early research (Phase 1)UnknownNCT04814004
What this trial is testing

Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell LymphomaChronic Lymphocytic Leukemia
Kai Lin Xu; Jun Nian Zheng 20
Testing effectiveness (Phase 2)Study completedNCT02750670
What this trial is testing

Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
University Health Network, Toronto 30
Early research (Phase 1)UnknownNCT03281551
What this trial is testing

Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma
Pinze Lifetechnology Co. Ltd. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100
Testing effectiveness (Phase 2)Looking for participantsNCT04110301
What this trial is testing

MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)

Who this might be right for
Follicular Lymphoma and Marginal Zone Lymphoma
Beijing Mabworks Biotech Co., Ltd. 53
Large-scale testing (Phase 3)Active Not RecruitingNCT02101853
What this trial is testing

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 669
Large-scale testing (Phase 3)Looking for participantsNCT06792253
What this trial is testing

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeBetter Med Inc 416
Not applicableActive Not RecruitingNCT04882475
What this trial is testing

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 160
Testing effectiveness (Phase 2)Ended earlyNCT06106841
What this trial is testing

TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Who this might be right for
Mantle Cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 19
Large-scale testing (Phase 3)Study completedNCT03391466
What this trial is testing

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Kite, A Gilead Company 359
Testing effectiveness (Phase 2)UnknownNCT01278602
What this trial is testing

R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Fudan University 50
Early research (Phase 1)Active Not RecruitingNCT03283137
What this trial is testing

Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL

Who this might be right for
CLLB-cell Non Hodgkin Lymphoma
University of Chicago 20
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)UnknownNCT01653067
What this trial is testing

STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Mathias Witzens-Harig 88
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01682044
What this trial is testing

Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma

Who this might be right for
Contiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Grade 3 Follicular Lymphoma+30 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00869999
What this trial is testing

Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Massachusetts General Hospital 26
Early research (Phase 1)Looking for participantsNCT01555892
What this trial is testing

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

Who this might be right for
Hodgkin's DiseaseNon-Hodgkin's LymphomaLymphoproliferative Disease+1 more
Baylor College of Medicine 136
Testing effectiveness (Phase 2)Study completedNCT00695409
What this trial is testing

Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 122
Next Page